Methicillin-Resistant Staphylococcus Aureus Drugs Market 2028 By Drug Class, Distribution Channel and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Drug Class
1.3.2 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Distribution Channel
1.3.3 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS - GLOBAL MARKET OVERVIEW
6.2. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. GLYCOPEPTIDES AND LIPOGLYCOPEPTIDES
7.3.1. Overview
7.3.2. Glycopeptides and Lipoglycopeptides Market Forecast and Analysis
7.4. OXAZOLIDINONES
7.4.1. Overview
7.4.2. Oxazolidinones Market Forecast and Analysis
7.5. LIPOPEPTIDES
7.5.1. Overview
7.5.2. Lipopeptides Market Forecast and Analysis
7.6. CEPHALOSPORIN
7.6.1. Overview
7.6.2. Cephalosporin Market Forecast and Analysis
7.7. TETRACYCLINE
7.7.1. Overview
7.7.2. Tetracycline Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.1.2 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.1.3 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.1.1 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.1.2 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.1.5.2 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.2.1 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.2.2 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.1.5.3 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.3.1 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.3.2 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.2.2 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.2.3 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.1.1 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.1.2 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.2 France Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.2.1 France Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.2.2 France Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.3 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.3.1 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.3.2 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.4 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.4.1 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.4.2 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.5.1 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.6.1 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.6.2 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.3.2 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.1.1 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.1.2 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.2 China Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.2.1 China Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.2.2 China Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.3 India Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.3.1 India Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.3.2 India Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.4 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.4.1 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.4.2 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.5 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.5.1 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.5.2 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.4.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.1.1 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.1.2 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.2.1 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.3 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.3.1 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.3.2 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.5.2 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.5.3 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.1.1 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.1.2 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5.5.2 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.2.1 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.2.2 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.3.1 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.3.2 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET, KEY COMPANY PROFILES
11.1. MERCK AND CO., INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBVIE INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BASILEA PHARMACEUTICA LTD.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALLERGAN PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. THERAVANCE BIOPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MELINTA THERAPEUTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CUMBERLAND PHARMACEUTICALS INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS